Research Background

Approximately 15 million individuals in the United States experience food allergy. Current therapeutic and preventive options are limited, creating a critical need to understand the underlying causes and disease progression. The National Institute of Allergy and Infectious Diseases (NIAID) has launched this long‑term observational study to elucidate the fundamental mechanisms of allergy.

Population and Design

The study enrolls food‑allergic patients aged 2 to 99 years, along with their relatives and healthy volunteers. Participants will undergo a minimum of three visits over 1–2 years, followed by annual visits for up to 12 years. This extended follow‑up enables systematic characterization of the natural history of food allergy.

Assessments and Data Collection

Blood sampling, skin prick testing, and leukocyte isolation are performed. Esophageal string testing, radiography, and other imaging modalities assess gastrointestinal status, while a broad range of clinical data are captured. The resulting genomic, immunologic, and microbiome datasets will constitute a valuable resource for uncovering allergy mechanisms.

Clinical and Industry Significance

The study provides foundational scientific evidence for a therapeutic area with few approved treatments. As data accumulate, they can be leveraged to discover novel biomarkers and therapeutic targets. Consequently, the research has the potential to reduce risk and create opportunities for companies developing allergy therapeutics and for investors.